Search

everythinglearnresearchcommunity

for

Search:↓

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Topical 5-Fluorouracil can rarely cause nerve damage, especially in people with a certain genetic deficiency.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

PLD is an effective and safer alternative for treating breast cancer.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Some medications can cause acne, and stopping these drugs is the main treatment.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.